🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with numerous of participants share “before and after” images, administration instructions and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in individuals administering substances of uncertain source.

Some experts stated the demand for the experimental drug could be linked to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and customer regulations, potentially leading to fines, legal action or prison.

Service Response and Content Elimination

Based on the social media company, the platform has removed violative content and prohibited related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and investing in strengthening compliance measures.

Online Trading Operations

Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.

Within moments of joining one group, a seller shared contact information, where most purchases occur. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Details and Pricing

Inside these communities, messages show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they cannot confirm. Although the science behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has previously encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to potentially significant health risks”.